|Call for Proposals||Release date||Deadline date|
Pharmacogenomics in Precision Medicine
30 September 2019
|5 November 2019 (midnight SAST)|
Target audience: Open call for researchers based at South African universities, science councils (including the SAMRC) and other public research organizations.
Topics: Pharmacogenomics in Precision Medicine
The SAMRC, through its Strategic Health Innovation Partnership (SHIP) programme, is seeking to fund five highly collaborative projects in the areas of pharmacogenomics with reference to failure of treatments with drugs (or drug classes) for Non-Communicable diseases, specifically Hypertension, Cardiovascular, Diabetes and Cancer in (South) Africa. This Request for Applications (RFA) is an open call for researchers based in South African public research institutions, who are conducting research focusing on:
The intent of this RFA is to support collaborative research that will advance the respective fields towards new products or solutions to address for Non-Communicable diseases, specifically Hypertension, Cardiovascular, Diabetes and Cancer in (South) Africa, with a focus on harnessing the core scientific strengths and areas of advantage in the country.
The SAMRC-SHIP has approved a total budget of R 12-14 million to fund eligible projects (at a maximum value of R3 million per project) for up to 3 years.
Proposals will only be considered for funding if they meet the funding eligibility requirements as specified in the RFA document.
All applications must be submitted on the SAMRC templates. Please see the links below for the relevant application documents.
Request for Applications Pharmacogenomics in Precision Medicine
Tuesday, November 5, 2019 - 23:59